P-01 analogs
- Generic Name
- P-01 analogs
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Phase 2
Terminated
- Conditions
- Dry Eye Disease
- Interventions
- Drug: P-321 Ophthalmic Solution placebo
- First Posted Date
- 2016-07-13
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Parion Sciences
- Target Recruit Count
- 47
- Registration Number
- NCT02831387
- Locations
- 🇺🇸
Sall Research Medical Center, Artesia, California, United States
🇺🇸Tauber Eye Center, Kansas City, Missouri, United States
🇺🇸Ophthalmology Associates, Saint Louis, Missouri, United States
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Phase 2
Terminated
- Conditions
- Dry Eye Disease
- Interventions
- Drug: P-321 Ophthalmic Solution placebo
- First Posted Date
- 2016-07-07
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Parion Sciences
- Target Recruit Count
- 1
- Registration Number
- NCT02824913
- Locations
- 🇺🇸
Bascom Palmer Eye Institute, University of Miami Health System, Plantation, Florida, United States
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
Phase 1
Completed
- Conditions
- Dry Eye Disease
- Interventions
- Drug: P-321 Ophthalmic Solution placebo
- First Posted Date
- 2014-09-16
- Last Posted Date
- 2015-05-04
- Lead Sponsor
- Parion Sciences
- Target Recruit Count
- 53
- Registration Number
- NCT02242032
- Locations
- 🇺🇸
Sall Research Medical Center, Artesia, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath